Oramed Pharmaceuticals adopts Rights Plan to protect against hostile takeover.
ByAinvest
Monday, Nov 17, 2025 8:54 am ET1min read
ORMP--
Oramed Pharmaceuticals' Board of Directors has adopted a Rights Agreement to protect against hostile takeovers and ensure fair treatment of all shareholders. A dividend of one common stock purchase right will be declared for each outstanding share of common stock. The Rights will enable shareholders to buy one share of common stock at $10.00 if they become exercisable. The plan aims to enhance the Board's negotiation power with prospective acquirors.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet